Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

85.95

-0.33 (-0.38%)

At close: Oct 29, 2026, 4:00 PM EDT

85.80

-0.15 (-0.18%)

After-hours: Oct 29, 2026, 4:52 PM EDT

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	9,291	3,661	5,280	3,348	2,186	2,097
Market Cap Growth	21.52%	-30.67%	57.69%	53.13%	4.24%	-30.98%
Enterprise Value	8,756	3,143	4,739	2,933	1,787	1,603
Last Close Price	86.28	34.80	50.39	32.48	20.31	19.80

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	189.46	37.29	37.78	31.74	21.59	18.64
Forward PE	22.40	55.53	32.11	32.61	19.95	21.01
PS Ratio	11.21	4.81	7.82	6.94	5.44	5.73
PB Ratio	13.19	5.65	7.77	6.61	4.36	5.58
P/TBV Ratio	13.19	5.65	7.77	6.61	4.36	5.58
P/FCF Ratio	87.09	25.82	26.92	26.46	18.23	12.53
P/OCF Ratio	84.88	25.78	26.63	26.43	18.17	12.49
PEG Ratio	-	1.96	1.96	1.96	1.96	1.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	10.56	4.13	7.02	6.08	4.45	4.38
EV/EBITDA Ratio	1085.65	68.40	34.40	27.08	15.69	12.73
EV/EBIT Ratio	1370.24	70.15	34.60	27.34	15.87	12.88
EV/FCF Ratio	82.08	22.17	24.16	23.18	14.90	9.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0	0.00	0.00
Debt / EBITDA Ratio	0.86	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.09	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.76	-0.81	-0.88	-0.84	-0.87	-0.89
Net Debt / EBITDA Ratio	-66.21	-11.45	-4.33	-3.93	-3.82	-2.66
Net Debt / FCF Ratio	-5.01	-3.71	-3.04	-3.36	-3.63	-2.00
Asset Turnover	0.98	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.11	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.50	2.60	3.11	4.05	6.60	5.31
Current Ratio	2.86	2.92	3.35	4.39	6.89	5.61
Return on Equity (ROE)	8.23%	15.02%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	0.47%	3.34%	11.71%	11.13%	13.98%	15.63%
Return on Invested Capital (ROIC)	1.79%	15.32%	54.21%	87.09%	87.74%	94.15%
Return on Capital Employed (ROCE)	0.90%	6.70%	19.60%	20.80%	22.00%	33.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.53%	2.72%	2.67%	3.17%	4.64%	5.36%
FCF Yield	1.15%	3.87%	3.72%	3.78%	5.48%	7.98%
Buyback Yield / Dilution	0.22%	-5.73%	-1.55%	3.64%	7.94%	-1.42%

SEC Filings: 10-K · 10-Q